prostate disease: A disease involving the prostate gland.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1340 |
4. Check minimum number of eventsNone |
1340 |
5. Include endpointsNone |
1340 |
6. Filter based on genotype QC (FinnGen only) |
1340 |
Control definitions (FinnGen only)
- Control exclude
- N14_MALEGEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N40-N51
- Name in latin
- Aliae morbositates prostatae
Other disorders of prostate
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10209 | - | 10209 |
| Only index persons | 8368 | - | 8368 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | - | 0.29 |
| Only index persons | 0.32 | - | 0.32 |
| Median age at first event (years) | |||
| Whole population | - | - | 67.24 |
| Only index persons | - | - | 65.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1340 | - | 1340 |
| Unadjusted period prevalence (%) | 0.59 | - | 0.59 |
| Median age at first event (years) | 66.21 | - | 66.21 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1192
- Matched controls
- 11919
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
1629.3
323.0
991
36
N40
ICD-10 Finland
Hyperplasia of prostate
10.2
253.6
612
1113
XKD00
NOMESCO Finland
Uroflowmetry
9.3
208.0
510
889
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
10.4
202.7
452
663
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
10.9
177.3
374
479
C61
ICD-10 Finland
Malignant neoplasm of prostate
7.0
167.3
506
1139
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
6.7
156.4
480
1083
TKE00
NOMESCO Finland
Needle biopsy of prostate
13.0
143.9
270
263
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
11.4
139.1
279
310
KED22
NOMESCO Finland
Transurethral resection of prostate
37.4
133.0
171
53
G04CA02
ATC
tamsulosin; oral
4.5
127.6
680
2704
UKC02
NOMESCO Finland
Cystoscopy
6.1
119.6
382
858
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
5.7
116.6
399
970
XJH00
NOMESCO Finland
Transanal ultrasonography
9.1
95.9
216
284
N42.8
ICD-10 Finland
Other specified disorders of prostate
71.8
92.2
105
16
116
Kela drug reimbursment
Prostate cancer
5.7
91.8
299
661
J01EA01
ATC
trimethoprim; systemic
5.8
89.2
283
604
J01MA02
ATC
ciprofloxacin; systemic
3.1
71.1
577
2766
G04CB02
ATC
dutasteride; oral
6.0
69.6
210
411
R33
ICD-10 Finland
Retention of urine
5.9
65.2
197
385
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
4.0
64.9
304
941
L02BB03
ATC
bicalutamide; oral
7.0
61.6
162
262
L02AE02
ATC
leuprorelin; implant, parenteral
4.8
48.9
176
413
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.5
47.4
181
451
R31
ICD-10 Finland
Unspecified haematuria
3.9
46.7
216
643
G04CA01
ATC
alfuzosin; oral
3.1
44.5
283
1077
XA402
NOMESCO Finland
ENMG
10.4
41.5
83
85
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
10.3
40.7
82
85
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
+∞
38.7
37
*
N42.0
ICD-10 Finland
Calculus of prostate
+∞
35.6
34
*
G04CA52
ATC
tamsulosin and dutasteride; systemic
3.2
33.0
195
691
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.8
31.3
81
126
TKC50
NOMESCO Finland
Training of urinary bladder
320.8
31.0
31
*
KGH10
NOMESCO Finland
Operation for phimosis
56.5
28.3
33
6
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.3
27.0
146
482
GD1AA
SPAT
NA
5.0
26.9
90
193
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
28.5
26.8
36
13
N30.0
ICD-10 Finland
Acute cystitis
4.2
26.6
105
266
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.9
26.2
177
678
XA420
NOMESCO Finland
Extensive sleep examination
11.3
26.0
49
45
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
24.4
281
1438
N41.0
ICD-10 Finland
Acute prostatitis
9.4
23.7
49
54
KED33
NOMESCO Finland
Transurethral incision of prostate
17.3
23.7
37
22
R35
ICD-10 Finland
Polyuria
3.8
23.6
103
286
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
14.9
23.5
39
27
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
23.3
159
614
A29
ICPC
General symptom/complaint other
2.9
23.0
150
562
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.9
22.7
52
68
WF090
NOMESCO Finland
Profylactic radiotherapy
14.5
22.7
38
27
N41.1
ICD-10 Finland
Chronic prostatitis
10.1
22.7
45
46
WF002
NOMESCO Finland
Radical radiotherapy
3.4
22.0
112
353
N02BE01
ATC
paracetamol; systemic, rectal
1.9
20.7
896
7331
J01MA06
ATC
norfloxacin; oral
3.1
20.5
120
416
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
20.5
138
526
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
20.4
328
1915
J01CA08
ATC
pivmecillinam; oral
3.5
20.2
98
297
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
6.4
19.7
52
84
J01DB01
ATC
cefalexin; oral
1.8
19.7
835
6710
XG460
NOMESCO Finland
Short time oxymetry
5.6
19.4
57
106
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.3
19.4
101
324
TKC22
NOMESCO Finland
Catheterisation instruction
10.0
19.2
38
39
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
4.5
19.0
69
162
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
16.5
18.4
29
18
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
16.5
18.4
29
18
UJF32
NOMESCO Finland
Coloscopy
2.0
18.1
293
1704
7451
FHL
Transurethral adenoma removal
33.4
18.0
23
7
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.8
18.0
45
68
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
17.8
124
483
N42.1
ICD-10 Finland
Congestion and haemorrhage of prostate
+∞
17.7
17
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
9.7
17.5
35
37
A02BC03
ATC
lansoprazole; oral
1.9
17.4
325
1986
7461
FHL
Needle biopsy in the operating room
21.2
17.3
25
12
WX702
NOMESCO Finland
Supraglottic ventilation device
4.1
17.2
69
178
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
8.3
16.8
37
46
R39.1
ICD-10 Finland
Other difficulties with micturition
4.8
16.8
56
121
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.0
16.6
54
113
U02
ICPC
Urinary frequency/urgency
3.5
16.4
79
239
N41.9
ICD-10 Finland
Inflammatory disease of prostate, unspecified
9.4
16.2
33
36
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
4.5
16.2
58
135
M54.5
ICD-10 Finland
Low back pain
1.9
16.1
274
1613
M01AH05
ATC
etoricoxib; oral
1.7
15.9
523
3791
G04BX04
ATC
NA
6.5
15.9
41
65
1530
FHL
Urethrocystoscopy
7.1
15.7
38
55
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
15.5
159
757
N43.4
ICD-10 Finland
Spermatocele
15.0
15.4
25
17
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
15.4
255
1484
ZX100
NOMESCO Finland
Oral
6.0
15.4
42
72
Y77
ICPC
Malignant neoplasm prostate
3.4
15.3
76
236
K30
ICD-10 Finland
Functional dyspepsia
2.8
15.2
100
373
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.3
15.1
144
662
A28
ICPC
Limited function/disability NOS
2.1
14.8
192
1016
N43.3
ICD-10 Finland
Hydrocele, unspecified
13.4
14.7
25
19
A02BC02
ATC
pantoprazole; systemic
1.6
14.6
658
5147
KED52
NOMESCO Finland
Visual laser resection of prostate
81.1
14.6
16
*
A02BC05
ATC
esomeprazole; systemic
1.7
14.4
384
2600
ZXA05
NOMESCO Finland
Left side
1.8
14.3
301
1895
J01MA01
ATC
ofloxacin; systemic
2.5
14.3
119
513
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
10.6
14.3
27
26
WW200
SPAT
NA
2.6
14.2
110
455
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
14.2
285
1768
L02AE01
ATC
buserelin; implant, nasal, parenteral
43.0
14.1
17
*
U01
ICPC
Dysuria/painful urination
6.1
13.8
37
62
ZX120
NOMESCO Finland
Intravenous
2.4
13.8
124
556
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
14.9
13.6
22
15
K29
ICPC
Cardiovascular sympt/complt other
3.2
13.2
71
234
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
13.2
260
1597
RTGOM
NOMESCO Finland
NA
40.5
13.2
16
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
12.9
80
290
G04BD08
ATC
solifenacin; oral
3.3
12.9
64
199
U08
ICPC
Urinary retention
6.0
12.9
35
60
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
8.2
12.8
28
35
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
12.7
878
7524
KDV10
NOMESCO Finland
Internal urethrotomy
14.5
12.3
20
14
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
12.2
327
2198
Z01.9
ICD-10 Finland
Special examination, unspecified
3.2
12.1
63
203
KC1GB
NOMESCO Finland
Cystography with X-ray
5.5
12.1
35
65
XG405
NOMESCO Finland
Education on PEF monitoring
5.8
12.0
33
58
L03
ICPC
Low back symptom/complaint
1.9
11.9
182
1022
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
11.9
395
2810
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
4.0
11.8
47
122
S59
ICPC
Skin, Other therap proced/minor surg NEC
5.9
11.8
32
55
N99.1
ICD-10 Finland
Postprocedural urethral stricture
14.8
11.8
19
13
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
11.7
427
3105
R53
ICD-10 Finland
Malaise and fatigue
1.8
11.7
201
1178
AA1AD
SPAT
NA
30.3
11.7
15
5
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
8.7
11.5
24
28
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.0
11.5
67
234
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
7.4
11.3
26
36
ZYC01
SPAT
NA
3.2
11.2
59
193
N02AX02
ATC
tramadol; systemic, rectal
1.5
11.1
469
3519
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
20.2
11.1
16
8
D19
ICPC
Teeth/gum symptom/complaint
1.8
11.1
194
1138
S01BC05
ATC
ketorolac; ophthalmic
2.7
11.1
76
292
N03AX16
ATC
pregabalin; oral
1.8
11.0
208
1253
XG410
NOMESCO Finland
Flow-volume spirometry
3.0
10.8
63
221
G04BD12
ATC
mirabegron; oral
2.4
10.7
90
387
A98
ICPC
Health maint/preventive medicine
1.6
10.7
939
8301
R50.9
ICD-10 Finland
Fever, unspecified
1.9
10.7
156
860
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
10.7
568
4484
N30.9
ICD-10 Finland
Cystitis, unspecified
4.0
10.7
41
104
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
5.4
10.6
31
59
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.1
10.6
56
184
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.7
10.6
245
1573
S02.5
ICD-10 Finland
Fracture of tooth
4.3
10.5
38
91
UKD02
NOMESCO Finland
Urethroscopy
14.3
10.5
17
12
60200
ICD-8 Finland
Other diseases of prostate, Sclerosis colli vesicae urinariae
+∞
10.4
10
*
U29
ICPC
Urinary symptom/complaint other
4.9
10.4
33
69
N32.0
ICD-10 Finland
Bladder-neck obstruction
12.2
10.4
18
15
ZXA00
NOMESCO Finland
Right side
1.6
10.3
302
2063
J01MA12
ATC
levofloxacin; systemic
1.7
10.3
218
1357
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
10.2
342
2416
R10.2
ICD-10 Finland
Pelvic and perineal pain
6.7
10.2
25
38
WX110
NOMESCO Finland
Local anesthesy
1.5
10.2
596
4782
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
5.3
10.2
30
58
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
10.2
226
1433
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.8
10.1
182
1078
M01AC06
ATC
meloxicam; systemic, rectal
1.6
10.1
310
2145
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
9.8
193
1177
J01CA04
ATC
amoxicillin; systemic
1.5
9.7
746
6312
KFD20
NOMESCO Finland
Excision of hydrocele of testis
55.4
9.7
11
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
7.9
9.6
21
27
J01AA04
ATC
lymecycline; systemic
2.2
9.6
103
499
R30.0
ICD-10 Finland
Dysuria
4.6
9.6
32
71
J02AC01
ATC
fluconazole; systemic
1.8
9.6
181
1089
6028X
ICD-9 Finland
Other disorders of prostate, Other specified disorders of prostate
+∞
9.4
9
*
6029X
ICD-9 Finland
Other disorders of prostate, Unspecified disorder of prostate
+∞
9.4
9
*
60209
ICD-8 Finland
Other diseases of prostate, Unspecified
+∞
9.4
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
9.4
121
637
OAB42
SPAT
NA
3.1
9.3
50
167
B01AB10
ATC
tinzaparin; parenteral
2.4
9.3
76
325
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
8.8
9.3
19
22
N48.1
ICD-10 Finland
Balanoposthitis
4.7
9.2
30
65
R01AD11
ATC
triamcinolone; nasal
2.4
9.2
76
328
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
9.2
109
554
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
9.2
351
2550
M01AX01
ATC
nabumetone; oral
3.1
9.1
48
158
R29
ICPC
Respiratory symptom/complaint other
2.7
9.1
62
241
N30.2
ICD-10 Finland
Other chronic cystitis
11.6
9.1
16
14
S18
ICPC
Laceration/cut
1.5
9.1
408
3074
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
9.0
422
3203
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.3
9.0
85
390
D45
ICPC
Digestive, Observ/health educat/advice/diet
37.0
9.0
11
*
U05
ICPC
Urination problems other
3.1
9.0
47
154
AXX01
SPAT
NA
6.6
9.0
22
34
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
6.1
8.9
23
38
XCH00
NOMESCO Finland
Eye pressure measurement
2.8
8.9
56
206
R82.7
ICD-10 Finland
Abnormal findings on microbiological examination of urine
24.2
8.9
12
5
N42
ICD-10 Finland
Other disorders of prostate
24.2
8.9
12
5
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
8.8
449
3466
M01AH01
ATC
celecoxib; oral (coxibs)
1.8
8.8
155
911
R05
ICPC
Cough
1.8
8.8
168
1012
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
8.7
8.8
18
21
L29
ICPC
Musculoskeletal sympt/complt other
2.6
8.8
63
251
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
8.7
202
1290
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.1
8.7
93
453
KFD30
NOMESCO Finland
Operation for spermatocele
50.3
8.7
10
*
KMAK
NOMESCO Finland
NA
1.5
8.7
402
3038
R43
ICPC
Respiratory, Other diagnostic procedure
7.7
8.7
19
25
N27
ICPC
Fear of neurological disease other
5.3
8.6
25
48
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
5.5
8.6
24
44
J01AA02
ATC
doxycycline; systemic
1.5
8.6
774
6671
EBA00
NOMESCO Finland
Extraction of tooth
1.5
8.6
302
2147
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
5.0
8.5
26
53
K02.1
ICD-10 Finland
Caries of dentine
1.5
8.5
450
3499
ZXC96
NOMESCO Finland
Robot assisted procedure
3.2
8.4
43
139
R06AE09
ATC
levocetirizine; oral
2.1
8.4
97
486
S29
ICPC
Skin symptom/complaint other
1.8
8.4
151
891
WX144
NOMESCO Finland
Subconjunctival anesthesy
5.1
8.4
25
50
B02AA02
ATC
tranexamic acid; systemic
2.5
8.3
65
273
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
8.3
225
1499
R06AE07
ATC
cetirizine; oral
1.5
8.3
297
2119
WZC30
NOMESCO Finland
Teaching
1.8
8.3
133
760
M25.5
ICD-10 Finland
Pain in joint
1.6
8.3
205
1335
S02.51
ICD-10 Finland
Fracture of tooth, open
2.2
8.2
84
400
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
14.6
8.2
13
9
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
14.6
8.2
13
9
H29
ICPC
Ear symptom/complaint other
2.1
8.1
89
439
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.2
8.1
41
132
R5120
NOMESCO Finland
Preparation of an aid
3.0
8.1
44
149
WNF00
NOMESCO Finland
Infection source and contact determination
8.2
8.1
17
21
Z29
ICPC
Social problem NOS
4.9
8.1
25
52
HMAK
NOMESCO Finland
NA
0.3
8.0
14
497
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.7
8.0
192
1238
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.9
157
958
NG1EA
SPAT
NA
13.1
7.9
13
10
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
7.9
140
825
U71
ICPC
Cystitis/urinary infection other
5.8
7.8
21
37
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
7.7
108
585
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.7
476
3789
N48.8
ICD-10 Finland
Other specified disorders of penis
45.2
7.7
9
*
N30.4
ICD-10 Finland
Irradiation cystitis
45.2
7.7
9
*
N06DX01
ATC
memantine; oral
2.1
7.7
88
443
U06
ICPC
Haematuria
3.5
7.6
33
95
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.6
107
581
C09CA06
ATC
candesartan; oral
1.6
7.6
191
1244
G04BE03
ATC
sildenafil; oral
3.6
7.6
32
90
WX320
NOMESCO Finland
Spinalanesthesy
1.6
7.5
191
1250
ZXH09
SPAT
NA
4.6
7.4
24
53
G04BD11
ATC
fesoterodine; oral
4.1
7.4
27
67
TKE10
NOMESCO Finland
Puncture of prostate
5.3
7.4
21
40
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.3
310
2287
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
7.3
101
545
60009
ICD-8 Finland
Hyperplasia of prostate, Unspecified
+∞
7.3
7
*
60500
ICD-8 Finland
Redundant prepuce and phimosis, Phimosis
+∞
7.3
7
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
7.3
116
660
N05CF01
ATC
zopiclone; oral
1.5
7.3
318
2360
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.1
7.1
36
117
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.1
7.1
83
418
B01AB05
ATC
enoxaparin; parenteral
1.5
7.1
292
2136
N48.4
ICD-10 Finland
Impotence of organic origin
3.9
7.1
27
70
Y06
ICPC
Prostate symptom/complaint
2.6
7.1
49
192
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
7.1
85
435
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
7.0
330
2480
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
4.7
7.0
22
47
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
7.0
434
3437
A02BA02
ATC
ranitidine; systemic
1.6
7.0
208
1417
K59.0
ICD-10 Finland
Constipation
2.4
7.0
58
252
WZC00
SPAT
NA
3.0
6.9
38
131
J02AC02
ATC
itraconazole; systemic
1.7
6.9
133
803
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
6.9
160
1019
D01BA02
ATC
terbinafine; oral; topical
1.5
6.9
266
1919
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.8
81
415
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
5.3
6.8
19
36
R51
NOMESCO Finland
Aids services
40.3
6.8
8
*
Y50
ICPC
Male Genital, Medication/prescr/renewal
16.8
6.7
10
6
S12
ICPC
Insect bite/sting
2.2
6.7
67
318
U07
ICPC
Urine symptom/complaint other
2.8
6.7
41
152
KH1AD
NOMESCO Finland
CT of urinary organs
2.8
6.7
40
146
A07EA02
ATC
hydrocortisone; rectal
3.2
6.6
32
101
Z01.2
ICD-10 Finland
Dental examination
1.5
6.6
276
2025
M03BX02
ATC
tizanidine; oral
1.4
6.6
482
3925
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.6
273
1998
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.6
340
2601
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
6.6
66
315
N20.0
ICD-10 Finland
Calculus of kidney
3.2
6.5
32
103
H13
ICPC
Plugged feeling ear
1.6
6.4
185
1245
WF099
NOMESCO Finland
Other radiotherapy
7.4
6.4
14
19
KE099
NOMESCO Finland
Other radiotherapy of prostata and seminal vesicles
14.4
6.4
10
7
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.8
6.4
25
67
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
6.4
211
1468
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.4
127
777
ZXH06
SPAT
NA
3.4
6.4
29
88
TKD00
NOMESCO Finland
Dilatation of urethra
8.2
6.3
13
16
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
6.0
6.3
16
27
WZA90
NOMESCO Finland
Other doctors statement
1.6
6.3
172
1147
7322
FHL
TU cervical electrosection or discission
18.1
6.3
9
5
60208
ICD-8 Finland
Other diseases of prostate, Alii definiti
+∞
6.3
6
*
N48.6
ICD-10 Finland
Induratio penis plastica
+∞
6.3
6
*
Y29
ICPC
Genital symptom/complaint male other
6.3
6.2
15
24
JN3AE
SPAT
NA
5.4
6.2
17
32
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
6.1
106
619
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.1
160
1056
XF404
NOMESCO Finland
Ambulatory ECG
1.8
6.1
97
553
M01AX17
ATC
nimesulide; oral
1.5
6.1
224
1598
F51.0
ICD-10 Finland
Nonorganic insomnia
2.0
6.1
74
384
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
12.6
6.1
10
8
A03
ICPC
Fever
1.8
6.1
97
555
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
6.1
41
162
J31.0
ICD-10 Finland
Chronic rhinitis
2.3
6.1
53
239
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.0
444
3605
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
6.0
100
579
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
450
1628
3.66
101.39
3.7
2.8
0.5
1.0
e6/l
4.79
357
951
403
1526
3.35
82.24
3.9
2.9
0.4
0.5
e6/l
0.74
307
864
565
2645
2.96
79.18
4.1
3.1
0.4
0.6
e6/l
0.34
490
2018
890
5437
2.90
73.24
5.7
3.6
131.2
2201.4
e6/l
—
9
117
395
1686
2.90
63.30
18.7
28.9
1.1
1.5
inr
—
8
255
567
2939
2.61
61.69
4.4
3.1
34.5
110.0
e6/l
2.28
495
2312
1014
7092
2.77
56.40
7.5
4.5
5.0
3.5
ug/l
0.90
940
6196
631
4029
2.07
36.49
4.1
3.0
0.0
0.0
estimate
0.00
66
710
800
5571
2.08
36.46
5.9
3.8
19.1
23.0
%
12.17
490
2576
627
4020
2.05
35.58
5.1
4.0
0.0
0.0
estimate
0.00
66
739
247
1082
2.57
35.52
3.0
3.1
6.9
11.4
umol/l
4.54
233
977
632
4084
2.04
34.88
4.2
3.0
0.0
0.0
estimate
0.00
63
676
615
3941
2.04
34.69
3.6
2.6
0.9
0.8
ug/l
1.03
458
2551
167
624
2.91
32.59
1.8
1.5
—
—
—
0
0
244
1143
2.39
29.99
2.4
2.1
12.6
12.8
nmol/l
0.08
210
994
631
4310
1.88
27.44
7.2
6.8
1.2
1.2
mmol/l
0.70
611
3910
329
1838
2.05
25.71
4.3
3.2
1.0
1.0
kg/l
0.23
17
267
243
1223
2.21
24.87
1.9
1.8
—
—
—
0
0
240
1224
2.17
23.67
1.9
1.8
—
—
—
0
0
914
7217
1.84
23.00
24.3
20.3
13.9
13.9
%
0.08
902
7009
341
2015
1.93
22.28
2.9
2.5
2.1
3.1
e6/l
4.33
303
1776
643
4726
1.69
19.42
6.9
7.5
1.2
1.2
mmol/l
1.29
591
3960
580
4223
1.66
17.61
4.7
4.2
—
—
—
0
0
877
7113
1.67
17.23
8.6
8.0
79.1
82.1
u/l
0.75
847
6692
655
4939
1.64
17.16
6.4
6.8
12.3
13.4
umol/l
2.00
636
4707
546
3965
1.64
16.42
4.8
3.9
56.7
64.1
ng/l
0.24
464
3089
448
3115
1.66
15.88
4.5
3.2
—
—
—
0
0
745
5891
1.60
15.38
5.5
5.4
6.9
7.0
mmol/l
1.71
722
5560
568
4232
1.59
14.97
2.5
2.2
—
—
—
0
0
667
5168
1.58
14.80
8.0
9.0
4.4
4.5
e9/l
0.24
588
4482
414
2878
1.63
14.41
2.8
2.7
56.7
59.5
u/l
0.78
401
2667
1031
8945
1.66
13.43
20.6
16.9
30.0
30.2
mg/l
0.05
882
7310
133
675
2.08
12.97
1.8
1.7
—
—
—
0
0
927
7869
1.58
12.90
22.5
18.2
40.3
39.7
%
1.39
756
5191
233
1430
1.76
12.75
5.4
7.7
0.8
0.8
mmol/l
0.01
184
1101
275
1776
1.69
12.50
1.9
1.9
—
—
—
0
0
148
815
1.92
11.44
3.3
2.9
66.0
63.5
ml/min/173m2
0.30
64
332
110
552
2.08
11.05
3.9
4.2
52.3
46.7
%
1.83
110
545
127
672
1.98
11.03
5.7
10.5
24.2
24.1
mmol/l
0.25
118
627
979
8541
1.54
10.90
18.4
15.9
74.4
76.0
ml/min/173m2
1.41
878
7091
40
1097
0.35
10.83
4.5
4.6
35.1
31.6
%
1.24
32
712
1076
9606
1.61
10.67
23.6
19.9
139.6
139.6
mmol/l
0.25
1064
9333
335
2358
1.56
10.53
1.5
1.6
18.5
18.9
nmol/l
0.20
296
2037
442
3315
1.50
10.30
3.3
3.2
2441.8
1928.3
ng/l
0.73
394
2927
1076
9638
1.59
10.17
23.6
20.1
4.1
4.0
mmol/l
0.82
1063
9353
68
290
2.42
10.11
1.4
1.8
—
—
—
0
0
394
2927
1.49
9.47
3.6
3.5
37.4
46.0
u/l
0.50
377
2768
62
265
2.40
9.20
1.4
1.8
—
—
—
0
0
1098
9962
1.57
8.96
28.5
24.0
229.6
229.2
e9/l
0.08
1079
9629
33
102
3.29
8.93
1.6
1.2
—
—
—
0
0
764
6467
1.42
8.93
4.1
3.8
11.7
14.0
mm/h
3.91
722
5908
1098
9965
1.56
8.91
28.6
24.0
4.5
4.5
e12/l
1.83
1069
9591
1098
9967
1.56
8.88
28.7
24.2
136.2
137.6
g/l
2.20
1091
9748
123
693
1.85
8.85
5.3
8.3
25.4
24.7
mmol/l
1.37
123
686
105
564
1.93
8.74
4.0
4.4
24.5
24.0
mmol/l
0.67
89
495
1065
9627
1.52
8.54
11.3
10.9
25.3
28.8
u/l
9.29
1050
9229
299
2140
1.51
8.49
3.9
4.0
289.7
548.0
ng/l
1.91
282
1883
982
8795
1.44
7.72
4.7
4.9
6.1
6.2
mmol/l
0.95
889
7894
141
863
1.71
7.66
2.4
2.6
49.8
47.4
u/l
0.06
114
747
76
390
2.01
7.24
4.4
3.9
3.9
4.0
mmol/l
1.33
76
353
678
5756
1.36
7.05
3.1
3.0
15.2
15.0
pmol/l
1.25
606
5114
170
1136
1.57
6.51
4.1
4.0
2.2
1.8
mmol/l
0.53
143
867
250
1814
1.46
6.49
2.1
2.1
30.6
30.5
s
0.09
245
1760
858
7642
1.34
6.05
3.9
3.6
2.0
2.1
mu/l
1.16
773
6784
300
2289
1.40
5.86
5.3
3.2
0.0
0.0
estimate
0.50
61
637
493
4068
1.34
5.86
2.0
2.1
91.9
89.8
pmol/l
0.49
283
2335
94
556
1.74
5.80
3.3
2.6
0.7
0.7
%
0.20
87
530
502
4187
1.32
5.43
4.9
5.4
34.6
34.4
g/l
0.33
477
3864
80
466
1.76
5.23
4.2
3.7
1.3
1.5
mmol/l
0.65
80
457
65
357
1.86
5.15
2.0
1.8
42.4
42.4
nmol/l
0.01
65
342
245
1845
1.40
5.12
1.7
1.7
1.2
1.7
mg/l
2.07
198
1453
989
9089
1.34
5.08
5.1
5.2
2.6
2.5
mmol/l
0.97
908
8283
967
8859
1.33
5.07
4.3
4.6
4.3
4.3
mmol/l
0.35
935
8130
326
2578
1.35
5.03
2.4
2.1
3.2
3.0
mg/l
0.30
293
2193
45
220
2.08
4.97
1.2
1.2
—
—
—
0
0
16
454
0.34
4.72
1.5
2.0
—
—
—
0
0
44
220
2.03
4.60
1.2
1.2
—
—
—
0
0
118
788
1.55
4.56
7.7
6.7
24.1
24.2
mmol/l
0.05
111
736
934
8568
1.30
4.52
5.7
6.5
40.4
41.4
mmol/mol
2.89
880
7846
407
3376
1.30
4.39
3.2
2.8
184.7
218.4
ug/l
1.15
383
3083
15
418
0.35
4.29
1.5
1.8
—
—
—
0
0
224
1721
1.36
4.11
2.5
3.3
2.4
2.4
mmol/l
0.01
175
1491
7
7
10.04
4.01
1.0
1.0
3.9
1.7
umol/l
—
7
7
217
1676
1.35
3.84
3.0
2.7
12.4
12.6
umol/l
0.19
204
1578
347
2894
1.27
3.48
3.3
3.4
2.3
2.3
mmol/l
0.28
309
2487
73
1108
0.64
3.45
4.2
3.5
—
—
—
0
0
944
8791
1.25
3.40
4.2
4.6
1.3
1.3
mmol/l
0.41
866
7992
35
184
1.93
3.26
1.7
1.7
—
—
—
0
0
140
1045
1.38
3.09
1.3
1.2
17.7
49.5
iu/ml
4.50
44
303
67
434
1.57
3.04
2.8
2.6
—
—
—
0
0
916
8550
1.23
2.99
3.8
4.1
1.3
1.3
mmol/l
0.65
833
7719
201
1596
1.31
2.94
3.1
2.7
2.1
2.2
g/l
0.99
187
1487
355
3026
1.24
2.88
2.0
2.0
80.5
75.2
nmol/l
2.88
310
2636
281
2340
1.25
2.81
2.6
2.8
—
—
—
0
0
148
1133
1.34
2.80
2.1
2.3
6.2
8.9
ug/l
1.92
142
1002
8
19
4.23
2.68
1.4
1.5
—
—
—
0
0
32
177
1.83
2.61
1.5
1.3
5.4
6.4
u/l
0.41
27
149
46
284
1.64
2.57
1.2
1.2
—
—
—
0
0
6
12
5.02
2.40
1.5
2.1
—
—
—
0
0
187
1519
1.27
2.31
3.2
2.7
22.9
22.9
%
0.00
168
1339
56
376
1.51
2.23
1.5
1.3
712.7
307.4
u/ml
0.47
51
335
138
1085
1.30
2.20
3.5
4.3
8.3
35.1
ug/l
2.01
112
925
7
20
3.51
2.05
1.0
1.0
—
—
—
0
0
168
2037
0.80
1.99
1.8
1.8
1206.9
1145.4
nmol/l
0.47
143
1548
95
725
1.33
1.90
3.8
3.3
128.8
128.4
g/l
0.06
95
707
22
121
1.83
1.89
1.6
1.5
—
—
—
0
0
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
18
93
1.95
1.85
1.5
1.3
117.1
402.8
pmol/l
—
6
27
26
152
1.72
1.84
1.3
1.5
—
—
—
0
0
20
108
1.86
1.82
1.1
1.3
2.1
5.9
u/ml
—
10
60
30
184
1.64
1.79
1.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
483
1.39
1.74
2.5
2.7
0.3
0.3
u/ml
0.95
39
258
46
317
1.47
1.68
1.3
1.3
—
—
—
0
0
37
244
1.53
1.66
1.5
1.6
0.2
28.0
iu/ml
—
10
49
124
1001
1.26
1.66
1.3
1.2
6.6
17.9
u/ml
0.92
49
364
94
739
1.29
1.56
1.6
1.7
—
—
—
0
0
56
407
1.39
1.56
2.7
2.5
3.1
3.1
g/l
0.04
47
325
7
28
2.51
1.45
1.3
1.1
—
—
—
0
0
5
16
3.13
1.44
1.4
1.2
—
—
—
0
0
7
152
0.46
1.43
1.0
1.1
1.5
1.6
g/l
—
7
142
13
66
1.98
1.43
1.3
1.4
—
—
—
0
0
59
441
1.35
1.41
2.7
2.5
—
—
—
0
0
59
441
1.35
1.41
2.7
2.5
3.9
4.0
g/l
0.38
46
318
9
179
0.50
1.40
8.8
3.6
49.9
58.8
%
—
9
179
59
442
1.35
1.39
2.7
2.5
7.3
7.3
g/l
0.04
48
328
6
23
2.62
1.37
1.0
1.0
1683.2
1511.0
miu/ml
—
6
23
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
15
260
0.57
1.35
5.4
3.6
1.7
1.8
mmol/l
0.13
15
255
0
38
0.00
1.34
0.0
2.2
—
—
—
0
0
0
38
0.00
1.34
0.0
2.2
—
—
—
0
0
0
38
0.00
1.34
0.0
2.2
—
—
—
0
0
19
113
1.69
1.32
1.1
1.3
1.4
3.8
u/ml
—
8
48
42
302
1.40
1.28
1.9
1.6
—
—
—
0
0
11
55
2.01
1.27
1.1
1.2
—
—
—
0
0
11
55
2.01
1.27
1.1
1.2
—
—
—
0
0
18
107
1.69
1.26
1.1
1.1
—
—
—
0
0
5
118
0.42
1.25
2.0
2.0
868.0
666.6
ml
—
5
59
13
70
1.87
1.24
1.1
1.1
0.4
3.3
u/ml
—
7
26
9
45
2.01
1.23
2.4
1.6
—
—
—
0
0
59
756
0.77
1.17
6.9
4.3
1.2
1.2
mmol/l
1.18
49
671
10
50
2.01
1.16
1.5
2.7
—
—
—
0
0
8
39
2.06
1.15
1.0
1.2
—
—
—
0
0
8
39
2.06
1.15
1.4
1.5
—
—
—
0
0
0
36
0.00
1.14
0.0
2.1
—
550.0
—
0
6
54
416
1.31
1.10
2.1
2.5
10.4
10.8
g/l
0.45
48
351
310
2820
1.13
1.09
3.4
2.9
1840.5
6786.5
umol/l
2.20
266
2424
26
177
1.48
1.08
1.3
1.1
—
—
—
0
0
11
59
1.87
1.07
1.5
2.7
—
—
—
0
0
26
180
1.45
1.01
1.5
1.2
3.7
3.8
mmol/l
0.22
26
166
150
1307
1.17
0.99
1.2
1.2
4.2
1.5
u/ml
0.75
39
344
25
173
1.45
0.98
1.2
1.2
—
—
—
0
0
0
31
0.00
0.96
0.0
1.1
—
15.1
—
0
26
32
233
1.38
0.96
1.0
1.2
0.4
1.3
u/ml
0.60
15
25
186
2084
0.88
0.94
1.7
1.7
422.5
35722878.1
pmol/l
2.14
166
1744
7
37
1.90
0.94
1.1
1.1
—
—
—
0
0
90
1066
0.83
0.92
3.1
2.9
272.9
256.8
ng/l
0.11
82
979
10
55
1.82
0.92
1.7
3.8
64.6
74.8
nmol/l
—
10
55
25
179
1.40
0.84
1.4
1.4
4.8
29.2
e6/l
0.79
20
144
110
953
1.17
0.81
2.9
2.6
66.7
66.2
g/l
0.30
103
870
8
48
1.67
0.78
1.6
1.2
11.4
13.3
iu/l
—
8
35
20
140
1.44
0.77
2.8
3.2
—
—
—
0
0
19
132
1.45
0.76
4.7
4.7
351.8
326.6
umol/l
0.24
14
113
10
59
1.70
0.76
2.6
2.9
—
—
—
0
0
11
67
1.65
0.75
1.5
1.3
—
—
—
0
0
5
24
2.09
0.74
15.0
9.2
6.3
5.3
mmol/l
—
5
24
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
21
150
1.41
0.73
1.3
1.6
—
—
—
0
0
11
171
0.64
0.72
1.0
1.1
—
93.8
—
0
33
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
28
364
0.76
0.69
1.8
2.2
252.0
91.8
ug/min
0.53
22
210
326
3473
0.92
0.66
3.5
4.1
13.6
9.6
mg/mmol
0.48
232
2421
127
1133
1.13
0.66
8.0
7.6
12.1
11.2
mmol/l
0.65
119
1072
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
6
102
0.59
0.62
1.8
1.5
—
—
—
0
0
30
235
1.28
0.61
1.6
1.7
15959.0
12915.5
e6/l
0.14
22
171
22
165
1.34
0.60
3.2
2.8
—
2510.3
—
0
16
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
12
80
1.50
0.60
1.3
1.5
1.8
1.2
promille
0.70
12
63
211
2279
0.91
0.59
1.6
1.6
1.3
1.4
mmol/l
0.78
166
1899
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
30
237
1.27
0.58
1.3
1.7
—
—
—
0
0
5
90
0.55
0.55
1.6
1.7
—
—
—
0
0
21
159
1.33
0.55
1.1
1.1
—
—
—
0
0
6
98
0.61
0.52
1.8
2.0
—
592.0
—
0
5
79
698
1.14
0.50
1.3
1.3
—
—
—
0
0
71
624
1.15
0.49
1.4
1.5
1.6
1.5
g/l
0.18
62
525
26
208
1.25
0.48
1.5
1.2
699.2
561.1
mg/l
0.54
26
189
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
32
264
1.22
0.46
1.0
1.0
—
—
—
0
0
7
49
1.43
0.46
1.0
1.0
296.7
339.3
mg/l
—
7
44
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
16
121
1.33
0.44
1.3
1.0
—
—
—
0
0
26
211
1.24
0.43
6.2
5.6
99.2
7376.0
iu/ml
—
5
34
21
166
1.27
0.43
1.2
1.5
—
—
—
0
0
156
1449
1.09
0.42
7.4
6.8
1.0
1.0
mmol/l
0.10
148
1349
8
57
1.41
0.42
1.5
1.7
—
—
—
0
0
18
140
1.29
0.42
1.2
1.2
296.4
264.1
u/ml
0.18
13
80
5
33
1.52
0.41
2.6
2.4
101.6
127.3
nmol/l
—
5
27
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
25
204
1.23
0.40
1.2
1.5
—
—
—
0
0
7
101
0.69
0.39
1.7
1.5
—
—
—
0
0
7
101
0.69
0.39
1.7
1.5
—
—
—
0
0
7
103
0.68
0.39
1.6
1.5
—
—
—
0
0
7
103
0.68
0.39
1.7
1.5
—
—
—
0
0
13
97
1.34
0.39
1.7
1.6
—
—
—
0
0
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
32
270
1.19
0.38
1.4
1.4
—
—
—
0
0
5
36
1.39
0.38
4.6
2.3
25.2
31.5
umol/l
—
5
25
9
69
1.31
0.37
1.1
1.2
—
—
—
0
0
16
125
1.28
0.37
1.3
1.7
—
—
—
0
0
26
216
1.21
0.37
1.7
1.5
—
—
—
0
0
30
253
1.19
0.37
1.2
1.7
—
—
—
0
0
153
1432
1.08
0.36
2.4
2.2
1.7
1.8
%
0.18
145
1264
11
81
1.36
0.36
1.0
1.0
216.2
299.0
ng/l
—
6
44
11
81
1.36
0.36
1.0
1.0
1146.7
661.8
ng/l
—
6
42
11
81
1.36
0.36
1.0
1.0
27.2
43.7
ng/l
—
6
42
6
42
1.43
0.35
1.0
1.2
120.4
249.4
iu/ml
—
6
42
20
163
1.23
0.34
1.4
1.3
—
—
—
0
0
117
1258
0.92
0.34
10.4
7.7
—
—
—
0
0
50
444
1.13
0.33
2.8
4.1
24.8
24.7
mmol/l
0.07
50
406
25
296
0.84
0.33
3.4
3.1
25.6
38.6
umol/l
1.92
20
248
63
569
1.11
0.32
2.1
2.0
—
—
—
0
0
26
220
1.19
0.32
2.0
1.7
—
—
—
0
0
7
100
0.70
0.30
1.7
1.5
—
—
—
0
0
15
185
0.81
0.30
1.6
1.4
—
—
—
0
0
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
113
1060
1.07
0.27
1.8
1.9
1.5
1.7
%
1.40
96
900
18
150
1.20
0.26
1.2
1.2
—
—
—
0
0
187
1791
1.05
0.24
2.8
3.3
0.8
0.8
mmol/l
0.29
179
1693
11
87
1.27
0.24
1.0
1.1
—
—
—
0
0
12
97
1.24
0.23
1.1
1.8
—
—
—
0
0
7
95
0.74
0.22
1.1
1.1
—
—
—
0
0
17
199
0.85
0.21
1.2
1.2
—
42.5
—
0
8
0
10
0.00
0.21
0.0
1.1
—
52.9
—
0
10
0
10
0.00
0.21
0.0
1.3
—
6717.1
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
11
89
1.24
0.21
1.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.3
1.1
38.3
20.1
u/l
—
6
39
10
81
1.24
0.18
1.0
1.1
—
—
—
0
0
6
53
1.13
0.18
1.2
2.3
189.8
217.7
u/l
—
6
53
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
6
78
0.77
0.15
1.2
1.5
—
—
—
0
0
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
329
3352
0.98
0.13
3.1
3.2
8.1
8.5
mmol/l
0.96
281
2801
96
999
0.96
0.13
1.9
2.4
0.2
0.2
g/l
0.06
89
914
24
220
1.09
0.12
1.4
1.6
233.4
240.2
ug/g
0.07
14
150
12
105
1.14
0.11
1.1
1.7
—
—
—
0
0
32
342
0.93
0.11
2.3
1.7
—
—
—
0
0
69
719
0.96
0.10
3.0
3.6
2.3
1.8
mmol/l
0.40
50
513
21
194
1.08
0.09
2.0
1.5
1597.7
1702.5
e6/l
0.05
15
140
6
54
1.11
0.09
1.3
1.1
87.8
95.8
u/l
—
6
44
19
175
1.09
0.08
1.1
1.2
—
—
—
0
0
5
64
0.78
0.08
1.2
1.7
—
—
—
0
0
6
70
0.86
0.07
4.8
3.2
—
—
—
0
0
6
70
0.86
0.07
1.5
1.3
—
—
—
0
0
6
70
0.86
0.07
1.5
1.3
—
—
—
0
0
20
186
1.08
0.07
1.2
1.8
—
—
—
0
0
24
227
1.06
0.06
1.2
1.4
—
—
—
0
0
11
100
1.10
0.05
1.0
1.2
11.6
7.4
mmol/l
—
5
78
16
150
1.07
0.04
1.3
1.5
—
—
—
0
0
564
5618
1.01
0.03
2.8
3.3
52.6
65.5
u/l
2.03
538
5162
19
182
1.04
0.02
2.1
1.5
9611.1
50196.4
e6/l
1.74
11
115
21
216
0.97
0.00
1.5
1.5
2.3
3.4
mg/l
—
10
154
33
326
1.01
0.00
2.0
2.3
3.9
3.7
g/l
0.28
33
306
24
239
1.00
0.00
1.7
1.3
—
—
—
0
0
24
239
1.00
0.00
1.7
1.3
—
—
—
0
0
30
301
1.00
0.00
1.4
1.4
—
—
—
0
0
13
133
0.98
0.00
1.2
1.2
—
—
—
0
0
28
277
1.01
0.00
1.1
1.2
31.5
122.5
iu/ml
—
7
91
10
105
0.95
0.00
2.4
3.2
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
18.7
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
5
57
0.88
0.00
2.4
2.2
645.6
454.1
e6/l
—
5
47
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
8
83
0.96
0.00
1.0
1.0
—
102.5
—
0
8
9
89
1.01
0.00
1.2
1.1
54.2
63.6
u/l
—
9
61
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
39
390
1.00
0.00
4.9
3.8
2.5
6.1
ratio
—
8
24
9
92
0.98
0.00
1.1
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
92
0.98
0.00
1.1
1.7
—
—
—
0
0
9
92
0.98
0.00
1.1
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
5
53
0.94
0.00
1.2
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_PROSTAOTH and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_PROSTAOTH | 1.179 [1.08, 1.29] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 2797 out of 7873 males with N14_PROSTAOTH died.
Mortality risk
Mortality risk for people of age
years, who have N14_PROSTAOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.215% |
| 5 | No data | 1.531% |
| 10 | No data | 3.6% |
| 15 | No data | 6.648% |
| 20 | No data | 11.126% |
Relationships between endpoints
↥Index endpoint: N14_PROSTAOTH – Other disorders of prostate
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data